Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

This is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

The programme – spearheaded by The Academic Respiratory Initiative for Pulmonary Health (Tariph) Centre under LKCMedicine – ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said of one patient.

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

EYLEA HD is anticipated to gain traction with the launch of a prefilled syringe in mid-2025 and label expansions for macular edema and extended dosing intervals. Management believes these developments ...

Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...